Protein parser Alamar Biosciences collects $128M to fund analyzer launch chale Fri, 03/01/2024 - 10:48.: The protein sequencing company Alamar Biosciences has collected $128 million in venture capital funding to boost the commercial roll out of its research hardware unveiled in the past year. The series C round—which includes an initial closing of $100 million, with the remaining $28 million expected to come in the next month, according to the company—was led by Sands Capital, and included backing from additional unnamed investors.